OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology
OPKO Health, Inc. (NASDAQ:OPK) today announced that... read more
OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology
OPKO Health, Inc. (NASDAQ:OPK) today announced that... read more
The data will be presented at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium (CHIPS), to be held March 15-17, 2018 at the Intercontinental Hotel in Hangzhou... read more
The FDA has granted Rare Pediatric Disease Designation for the ABO-202 program (AAV-CLN1), an AAV-based gene therapy for the treatment of CLN1 disease (infantile and late infantile onset... read more
This act, sponsored by Louise Slaughter D-NY, directs the Attorney General to establish a stewardship program to facilitate the collection and disposal of prescription medication. The apparent... read more
The MasSpec Pen has been awarded the SXSW Interactive Innovation Award in the Health, Med and Biotech category. The MasSpec Pen is a handheld device that allows surgeons to identify cancerous... read more